Login / Signup

The effects of esketamine and treatment expectation in acute major depressive disorder (Expect): study protocol for a pharmacological fMRI study using a balanced placebo design.

Irina FalkenbergFlorian BitschWei LiuAlexandros MatsingosLaila NoorChristoph VogelbacherCüneyt YildizTilo Kircher
Published in: Trials (2023)
This trial has been prospectively registered with the EU Clinical Trials Register: EudraCT-No.: 2020-000784-23 (November 17, 2020).
Keyphrases
  • major depressive disorder
  • clinical trial
  • phase iii
  • bipolar disorder
  • phase ii
  • liver failure
  • functional connectivity
  • resting state
  • respiratory failure
  • open label
  • double blind
  • intensive care unit